Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis.
Fernández-Cruz A, Semiglia MA, Guinea J, Martínez-Jiménez MDC, Escribano P, Kwon M, Rodríguez-Macías G, Chamorro-de-Vega E, Rodríguez-González C, Navarro R, Galar A, Sánchez-Carrillo C, Díez-Martín JL, Muñoz P. Fernández-Cruz A, et al. Med Mycol. 2020 Apr 1;58(3):300-309. doi: 10.1093/mmy/myz060. Med Mycol. 2020. PMID: 31231772
Training should be the first step toward an antifungal stewardship program.
Valerio M, Muñoz P, Rodríguez-González C, Sanjurjo M, Guinea J, Bouza E; COMIC study group (Collaborative group on Mycosis). Valerio M, et al. Enferm Infecc Microbiol Clin. 2015 Apr;33(4):221-7. doi: 10.1016/j.eimc.2014.04.016. Epub 2014 Jul 24. Enferm Infecc Microbiol Clin. 2015. PMID: 25066382
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice.
Chamorro-de-Vega E, Gimenez-Manzorro A, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, Collado Borrell R, Ibañez-Garcia S, Lallana Sainz E, Lobato Matilla E, Lorenzo-Pinto A, Manrique-Rodriguez S, Fernandez-Llamazares CM, Marzal-Alfaro M, Ribed A, Romero Jimenez RM, Sarobe Gonzalez C, Herranz A, Sanjurjo M. Chamorro-de-Vega E, et al. Ann Pharmacother. 2016 Nov;50(11):901-908. doi: 10.1177/1060028016659306. Epub 2016 Jul 20. Ann Pharmacother. 2016. PMID: 27422641
Dalbavancin in the treatment of different gram-positive infections: a real-life experience.
Bouza E, Valerio M, Soriano A, Morata L, Carus EG, Rodríguez-González C, Hidalgo-Tenorio MC, Plata A, Muñoz P, Vena A; DALBUSE Study Group (Dalbavancina: Estudio de su uso clinico en España). Bouza E, et al. Int J Antimicrob Agents. 2018 Apr;51(4):571-577. doi: 10.1016/j.ijantimicag.2017.11.008. Epub 2017 Nov 24. Int J Antimicrob Agents. 2018. PMID: 29180276
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study.
Chamorro-de-Vega E, Gimenez-Manzorro A, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, De Lorenzo-Pinto A, Iglesias-Peinado I, Herranz-Alonso A, Sanjurjo Saez M; GRUviC Study Group. Chamorro-de-Vega E, et al. Expert Opin Drug Saf. 2018 Mar;17(3):235-241. doi: 10.1080/14740338.2018.1424829. Epub 2018 Jan 11. Expert Opin Drug Saf. 2018. PMID: 29325476
83 results